Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to determine the feasibility of implementing a 24-week at-home chair-based resistance band training intervention, to determine effectiveness of a the a 24-week at-home chair-based resistance band training intervention in improving body composition and to determine the effectiveness of a 24-week at-home chair-based resistance band training intervention in improving physical performance in adults 50 years and older, receiving care at the UT Physicians Center for Healthy Aging.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Chair-based resistance band training | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| THERABand resistance exercise bands | Device | The training will be performed using THERABand resistance exercise bands.Participants will be instructed to perform the exercises twice per week at home, for the 24 weeks duration. Each exercise session will entail 1 set of 15 repetitions of 9 different exercises |
| Measure | Description | Time Frame |
|---|---|---|
| Feasibility as assessed by the number of people who are able to follow the prescribed exercise regimen at least 50 percent of the time | end of study (24 weeks from baseline) |
| Measure | Description | Time Frame |
|---|---|---|
| Change in body fat | This will be assessed using the handheld bioelectrical impedance analysis (BIA) device (Omron HBF-510) | baseline,6-months |
| Change in bone mineral density (BMD) of the femoral neck and lumbar spine |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Nahid Rianon, MBBS,DrPH | Contact | (713) 500-5106 | Nahid.J.Rianon@uth.tmc.edu | |
| Jude des Bordes, MBChB, DrPH | Contact | (713) 500-6029 | Jude.K.desBordes@uth.tmc.edu |
| Name | Affiliation | Role |
|---|---|---|
| Nahid Rianon, MBBS, DrPH | The University of Texas Health Science Center, Houston | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| The University of Texas Health Science Center at Houston | Houston | Texas | 77479 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
This will be assessed by the Dual energy x-ray absorptiometry (DXA)
| baseline, 1 year from baseline |
| Handgrip strength | This will be assessed using a validated handgrip dynamometer | baseline |
| Handgrip strength | This will be assessed using a validated handgrip dynamometer | 1-month |
| Handgrip strength | This will be assessed using a validated handgrip dynamometer | 3-months |
| Handgrip strength | This will be assessed using a validated handgrip dynamometer | 6-months |
| 60-second balance as assessed by the the Zibrio Stability Pro scale | This is determined by the patient standing on the Zibrio Stability Pro Scale unassisted for one minute and will be measured on a scale of 1 to 9 with lower scores indicating higher risk of fall | Baseline |
| 60-second balance as assessed by the the Zibrio Stability Pro scale | This is determined by the patient standing on the Zibrio Stability Pro Scale unassisted for one minute and will be measured on a scale of 1 to 9 with lower scores indicating higher risk of fall | 1-month |
| 60-second balance as assessed by the the Zibrio Stability Pro scale | This is determined by the patient standing on the Zibrio Stability Pro Scale unassisted for one minute and will be measured on a scale of 1 to 9 with lower scores indicating higher risk of fall | 3-months |
| 60-second balance as assessed by the the Zibrio Stability Pro scale | This is determined by the patient standing on the Zibrio Stability Pro Scale unassisted for one minute and will be measured on a scale of 1 to 9 with lower scores indicating higher risk of fall | 6-months |
| walking gait speed | Gait speed will be assessed over a 6-meter distance measured within a private clinic space. The participant will be instructed to walk at their normal walking pace (as if they were walking throughout the house) and the distance/time will be converted to meters/second.Faster walking speed is related to reduced fall-risk, improved physical function, and greater survival . | Baseline |
| walking gait speed | Gait speed will be assessed over a 6-meter distance measured within a private clinic space. The participant will be instructed to walk at their normal walking pace (as if they were walking throughout the house) and the distance/time will be converted to meters/second.Faster walking speed is related to reduced fall-risk, improved physical function, and greater survival . | 1-month |
| walking gait speed | Gait speed will be assessed over a 6-meter distance measured within a private clinic space. The participant will be instructed to walk at their normal walking pace (as if they were walking throughout the house) and the distance/time will be converted to meters/second.Faster walking speed is related to reduced fall-risk, improved physical function, and greater survival . | 3-months |
| walking gait speed | Gait speed will be assessed over a 6-meter distance measured within a private clinic space. The participant will be instructed to walk at their normal walking pace (as if they were walking throughout the house) and the distance/time will be converted to meters/second.Faster walking speed is related to reduced fall-risk, improved physical function, and greater survival . | 6-months |
| Blood level of pro-collagen type 1 N-telopeptide (P1NP) | P1NP is a metabolic marker of bone formation, indicates status of bone loss and a stable or decreased level will be indicating improved metabolism | Baseline |
| Blood level of pro-collagen type 1 N-telopeptide (P1NP) | P1NP is a metabolic marker of bone formation, indicates status of bone loss and a stable or decreased level will be indicating improved metabolism | 6 months |
| Frailty as assessed by the Fried criteria | This consists of 5 items (unintentional weight loss, weakness [low grip strength], slowness low, self-reported exhaustion and low physical activity). Patients who meet 1or 2 of the criteria are described as pre-frail and 3 or more as frail. | Baseline |
| Frailty as assessed by the Fried criteria | This consists of 5 items (unintentional weight loss, weakness [low grip strength], slowness low, self-reported exhaustion and low physical activity). Patients who meet 1or 2 of the criteria are described as pre-frail and 3 or more as frail. | 1-month |
| Frailty as assessed by the Fried criteria | This consists of 5 items (unintentional weight loss, weakness [low grip strength], slowness low, self-reported exhaustion and low physical activity). Patients who meet 1or 2 of the criteria are described as pre-frail and 3 or more as frail. | 3-months |
| Frailty as assessed by the Fried criteria | This consists of 5 items (unintentional weight loss, weakness [low grip strength], slowness low, self-reported exhaustion and low physical activity). Patients who meet 1or 2 of the criteria are described as pre-frail and 3 or more as frail. | 6-months |